Levocarnitine Supplementation Suppresses Lenvatinib-Related Sarcopenia in Hepatocellular Carcinoma Patients: Results of a Propensity Score Analysis

This study investigated the inhibitory effect of levocarnitine supplementation on sarcopenia progression in hepatocellular carcinoma (HCC) patients treated with lenvatinib. We evaluated the skeletal muscle index (SMI). After propensity score matching for age, sex, modified albumin-bilirubin grade, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Okubo, Hironao, Ando, Hitoshi, Nakadera, Eisuke, Ikejima, Kenichi, Shiina, Shuichiro, Nagahara, Akihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705344/
https://www.ncbi.nlm.nih.gov/pubmed/34959980
http://dx.doi.org/10.3390/nu13124428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705344/
https://www.ncbi.nlm.nih.gov/pubmed/34959980
http://dx.doi.org/10.3390/nu13124428

Ejemplares similares